Hangzhou Pushai Pharmaceutical has a total of 28 patents globally, out of which 1 have been granted. Of these 28 patents, more than 2% patents are active. China is where Hangzhou Pushai Pharmaceutical has filed the maximum number of patents, followed by United States of America. Parallelly, China seems to be the main focused R&D centre and also is the origin country of Hangzhou Pushai Pharmaceutical.
Hangzhou Pushai Pharmaceutical was founded in 2012. The company focuses on the development, production, and commercialization of novel pharmaceutical products, particularly those involving advanced crystal forms and drug formulations.
Do read about some of the most popular patents of Hangzhou Pushai Pharmaceutical which have been covered by us in this article and also you can find Hangzhou Pushai Pharmaceutical patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Hangzhou Pushai Pharmaceutical patent portfolio.
How many patents does Hangzhou Pushai Pharmaceutical have?
Hangzhou Pushai Pharmaceutical has a total of 28 patents globally. These patents belong to 23 unique patent families. Out of 28 patents, 1 patent is active.
How Many Patents did Hangzhou Pushai Pharmaceutical File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Hangzhou Pushai Pharmaceutical Applications Filed | Hangzhou Pushai Pharmaceutical Patents Granted |
| 2017 | – | 1 |
| 2015 | 4 | – |
| 2014 | 17 | – |
| 2013 | 7 | – |
How many Hangzhou Pushai Pharmaceutical patents are Alive/Dead?
Worldwide Patents
How Many Patents did Hangzhou Pushai Pharmaceutical File in Different Countries?
Countries in which Hangzhou Pushai Pharmaceutical Filed Patents
| Country | Patent |
| China | 6 |
| United States of America | 1 |
Where are Research Centers of Hangzhou Pushai Pharmaceutical Patents Located?
The Research Centers of Hangzhou Pushai Pharmaceutical Patents is China.
10 Best Hangzhou Pushai Pharmaceutical Patents
WO2015035802A1 is the most popular patent in the Hangzhou Pushai Pharmaceutical portfolio. It has received 35 citations so far from companies like Wante Pharmaceutical, Anhui Runsheng Pharmaceutical, Shandong Taihe Pharmaceutical Technology.
Below is the list of 10 most cited patents of Hangzhou Pushai Pharmaceutical:
| Publication Number | Citation Count |
| WO2015035802A1 | 35 |
| WO2015014315A1 | 15 |
| WO2015139591A1 | 13 |
| WO2015180060A1 | 13 |
| WO2015007206A1 | 11 |
| WO2015109445A1 | 9 |
| US20160200698A1 | 8 |
| WO2015096119A1 | 7 |
| WO2015054804A1 | 7 |
| WO2015139386A1 | 6 |
List of Hangzhou Pushai Pharmaceutical patents
| Hangzhou Pushai Pharmaceutical Patents | Title |
| CN105121434B | Canagliflozin Monohydrate And Its Crystal Forms, Their Preparation Method And Use |
| US20160200698A1 | Vortioxetine Salt And Crystal Thereof, Their Preparation Method, Pharmaceutical Compositions And Usage |
| CN105461698A | Cediranib Salt And Crystal Form Thereof, And Preparation Methods And Pharmaceutical Composition Of Cediranib Salt And Crystal Form Thereof |
| CN105384730A | Empagliflozin Crystal Forms, Preparation Methods And Uses Thereof, And Pharmaceutical Composition |
| CN104109159A | New Crystal Forms Of Benzene Sulfonamide Thiazole And Preparation Method Thereof |
| CN106279122A | Salt, Crystal Form And Amorphic Substance Of Compound, Preparation Methods Of Salt, Crystal Form And Amorphic Substance Of Compound, Pharmaceutical Composition Containing Salt, Crystal Form And Amorphic Substance Of Compound And Application |
| CN106543085A | Solid Form Of Enzalutamide And Preparation Method And Application Of Solid Form |
| WO2015007206A1 | Afatinib Acid Addition Salts And Crystal Forms Thereof, Preparation Method And Pharmaceutical Composition Thereof |
| WO2015139386A1 | Canagliflozin Monohydrate And Crystal Form Thereof, Preparation Method And Use Thereof |
| WO2015106674A1 | Crystal Form Of Anacetrapib And Preparation Method, Pharmaceutical Composition And Use Thereof |
| WO2014169770A1 | Crystal Form Of Dabrafenib And Preparation Method And Use Thereof |
| WO2015158202A1 | Crystal Form Of Oxazolidinone Antibiotics And Preparation Method, Composition And Use Thereof |
| WO2015035531A1 | Crystal Form Of Regorafenib Salt And Preparation Method And Application Thereof |
| WO2015149270A1 | Crystal Of Trelagliptin Semi-Succinate And Preparation Method And Pharmaceutical Composition Thereof |
| WO2015180253A1 | Crystalline Form Of Anti-Hepatitis C Virus Drug, Preparation Method Therefor, And Pharmaceutical Composition And Use Thereof |
| WO2015139591A1 | Crystalline Form Of Dolutegravir Sodium Salt And Preparation Method Therefor |
| WO2015109925A1 | Crystalline Form Of Hepatitis C Drug And Preparation Method, Pharmaceutical Composition And Use Thereof |
| WO2015081566A1 | Crystalline Forms Of Trametinib And Solvate Thereof, Preparation Method Therefor, Pharmaceutical Composition Comprising Same And Use Thereof |
| WO2015161730A1 | Eutectic Crystal Of Lorcaserin And Preparation Method, Pharmaceutical Composition And Use Thereof |
| WO2015014315A1 | Inhibitor Crystalline Form And Preparation Method And Use Thereof |
| WO2015096119A1 | Lorcaserin Salts And Crystals Thereof, Preparation Methods And Uses Thereof |
| WO2014198178A1 | Macitentan Crystal, Preparation Method Therefor, Pharmaceutical Composition And Use Thereof |
| WO2015003571A1 | Novel Crystal Form Of Dabrafenib Mesylate And Preparation Method Thereof |
| WO2015074281A1 | Rigosertib Salt, Crystal Form Thereof, And Their Preparation Method And Application |
| WO2015109445A1 | Salt Of Compound And Crystalline Or Amorphous Substance Thereof, Preparation Method Therefor, Pharmaceutical Composition Containing Same And Use Thereof |
| WO2015180060A1 | Salt Of Diazacycloheptane Compound And Crystal Form And Amorphous Substance Thereof |
| WO2015054804A1 | Solid Form Of Enzalutamide, Preparation Method And Use Thereof |
| WO2015035802A1 | Vortioxetine Salt And Crystal Thereof, Their Preparation Method, Pharmaceutical Compositions And Usage |
What are Hangzhou Pushai Pharmaceutical key innovation segments?
What Technologies are Covered by Hangzhou Pushai Pharmaceutical?
The chart below distributes patents filed by Hangzhou Pushai Pharmaceutical in different countries on the basis of the technology protected in patents. It also represents the markets where Hangzhou Pushai Pharmaceutical thinks it’s important to protect particular technology inventions.
R&D Focus: How has Hangzhou Pushai Pharmaceutical search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Hangzhou Pushai Pharmaceutical?